Georgios S. Papaetis
Georgios S. Papaetis publishes mostly in Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery, on topics such as Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer and Pneumocystis jirovecii pneumonia detection and treatment.
- World rank
- #2,712,754 of 7,710,434 ranked researchers
- Rank in Cyprus
- #1,383 of 3,055
- Works
- 48
- Citations
- 746
- Citations per work
- 15.5
What does Georgios S. Papaetis research?
Georgios S. Papaetis's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2859.2%
- Medicine2859.2%
- Everything else1734.5%
- Life Sciences36.3%
- 1Endocrinology, Diabetes and Metabolism19% of their works
- 2Epidemiology16% of their works
- 3Surgery10% of their works
- 4Cardiology and Cardiovascular Medicine9% of their works
- 5Molecular Biology6% of their works
- 6Pulmonary and Respiratory Medicine6% of their works
Research topics
- Diabetes Treatment and Management
- Metabolism, Diabetes, and Cancer
- Pneumocystis jirovecii pneumonia detection and treatment
- Pancreatic function and diabetes
- Peroxisome Proliferator-Activated Receptors
- Cardiac tumors and thrombi
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
Which keywords describe Georgios S. Papaetis's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Outcomes, Type 2 Diabetes, Diabetes, Cardiovascular Disease, Obesity and AMP-Activated Protein Kinase.
- PRKAR1A Gene Mutations
- Metabolic Syndrome
- Hypoglycemia
- Cardiac Tumors
- Pneumonia
- Pancreatic Islets
- AMP-Activated Protein Kinase
- Cardiovascular Disease
- Type 2 Diabetes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Outcomes
- Diabetes
- Obesity
- Metformin
- Pneumocystis
- ß-Cell Dysfunction
- Continuous Glucose Monitoring
- Insulin Resistance
- PPARs
- Peroxisome Proliferator-Activated Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Glycemic Control192 topics
- Insulin Therapy192 topics
- Cardiovascular Outcomes151 topic
- Type 2 Diabetes151 topic
- Diabetes123 topics
- Cardiovascular Disease82 topics
- Obesity82 topics
- AMP-Activated Protein Kinase51 topic
- Metformin51 topic
- Pancreatic Islets51 topic
- Pneumocystis51 topic
- Pneumonia51 topic
- ß-Cell Dysfunction51 topic
- Cardiac Tumors41 topic
- Continuous Glucose Monitoring41 topic
- Hypoglycemia41 topic
- Insulin Resistance41 topic
- Metabolic Syndrome41 topic
- PPARs41 topic
- PRKAR1A Gene Mutations41 topic
- Peroxisome Proliferator-Activated Receptors41 topic
Where does Georgios S. Papaetis work?
Georgios S. Papaetis's main affiliation in the publication record is Paphos General Hospital, Cyprus.
How many publications and citations does Georgios S. Papaetis have?
OpenAlex counts 48 works and 746 citations for Georgios S. Papaetis, an h-index of 14, ranking #2,712,754 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Georgios S. Papaetis. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.